Pomerantz LLP announces that a class action lawsuit has been filed
against Recro Pharma, Inc. (“Recro” or the “Company”)
REPH, +0.80%
and
certain of its officers. The class action, filed in United States
District Court, Eastern District of Pennsylvania, …
Go to Source